Overview

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

Status:
Unknown status

Trial end date:
2010-06-01

Target enrollment:

Participant gender:

Summary

This is s randomized, multi-center, double blind, 3 arm, phase I/II pilot study to evaluate the safety and efficacy of treatment with ORA102 combined with Avastin (Bevacizumab) versus Avastin alone, in patients with neo-vascular age related macular degeneration (AMD).

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Ora Bio Ltd.

Treatments:

Bevacizumab